Navigation Links
VetStem Biopharma Proudly Announces Dr. Mark Hughes as the Senior Manager, Veterinary Clinical Research and Safety
Date:6/20/2016

VetStem Biopharma proudly announces Dr. Mark Hughes as the Senior Manager, Veterinary Clinical Research and Safety. Dr. Hughes, former Product Development Manager in R&D at Virbac Corporation, brings eight years of experience managing drug development projects through the process of pharmaceutical development, preclinical and clinical trials, and submissions to regulatory authorities for marketing approval in the US and Canada. Dr. Hughes received BS, MS, and DVM degrees from the University of California, Davis, and is licensed to practice in California. He also has provided commercial embryo transfer services for beef and dairy cattle, developed in-vitro diagnostics for diseases in animals and people, and managed a laboratory animal research facility.

“With 8 years of experience in the veterinary product development market and having extensive experience in clinical field trials Dr. Hughes will be a great addition to our team.” Dr. Robert Harman, CEO, explains. “Dr. Hughes will be responsible for the continued development of new services, products and clinical data generation. We believe with his previous history and understanding of the product development process, he will efficiently guide our projects through the FDA approval process.”

“I am very pleased to join the VetStem Biopharma team to be an integral part of a dynamic, industry-leading company in a field with breakthrough potential for treating a diverse range of diseases and injuries in companion animals and horses,” said Dr. Hughes. “I am excited to participate in the development of products that truly will benefit our animal friends worldwide.”

VetStem is currently in the product development phase for the first off-the-shelf stem cell product for the canine osteoarthritis. As many as two thirds of dogs over 7 years old are affected by osteoarthritis, which has created the largest existing market segment in pet therapeutics. Although currently marketed products can help decrease the crippling symptoms of osteoarthritis, they are not designed to regenerate and heal the damaged tissue that is causing pain. Regenerative medicine focuses on true regeneration of damaged tissues and organs.

About VetStem Biopharma
VetStem Biopharma is a veterinarian-lead company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego (California), currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 14 years and 12,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality beyond the realm of research. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. The company’s stated mission being “to extend and enhance the lives of animals by improving the quality of recovery in acute conditions, but also by unlocking ways to slow, stop and ultimately revert the course of chronic diseases”. In addition to its’ own portfolio of patents, VetStem holds exclusive global veterinary licenses to a portfolio of over 55 issued patents in the field of regenerative medicine.

Read the full story at http://www.prweb.com/releases/2016/06/prweb13467382.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. VetStem Biopharma is Pleased to Share the Success Story of Koda Who was Treated at Advanced Care Veterinary Services with Stem Cell Therapy.
2. VetStem Biopharma Regenerative Cell Therapy Has Been Used on over 12,000 Animals
3. VetStem Biopharma is Pleased to Share the Success Story of Lady Who Was Treated at Aloha Pet and Bird Hospital with Stem Cell Therapy
4. VetStem Biopharma is Happy to Announce Several of its Veterinary Clients have Surpassed the Centennial Mark by Performing VetStem Cell Therapy on over 100 Patients.
5. VetStem Biopharma Shares News of the Successful Treatment of a Non-healing Chronic Wound and Rear Leg Lameness, with the New Pall V-PET™ Platelet Therapy System
6. VetStem Biopharma Announces OC Mobile Surgery now offers Stem Cell therapy for dogs and cats suffering from orthopedic conditions
7. New Book Out with Two Chapters on Veterinary Regenerative Medicine Written by Dr. Bob Harman, CEO for VetStem Biopharma, Now Available through Amazon
8. VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, to Speak at the International Canine Sports Medicine Symposium
9. Peak Performance Veterinary Group and VetStem Biopharma, Announce Educational and Clinical Partnership in Support of Local Area Veterinarians
10. VetStem Biopharma and PALL Life Sciences announce a clinical research/technology distribution agreement for Pall’s Veterinary Platelet Enhancement Therapy system V-PET™
11. VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, to Present at Third Annual Clinical and Surgical Translation of Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2019)... FORT WORTH, Texas (PRWEB) , ... August 13, ... ... in Fort Collins, Colorado to focus on prepackaged mobile phases for QC laboratories. ... to reinvent Chata from its laboratory sciences approach into a valued supplier of ...
(Date:8/6/2019)... ... August 06, 2019 , ... The San Diego Biotechnology ... the biweekly SDBN BUZZ podcast focused on connecting the region’s biotech community and ... to promote the region and attract external employers, investors, scientists, and others who ...
(Date:8/6/2019)... ... August 06, 2019 , ... ... Edwardsville for the launch of a community project that will engage middle and ... supports the project, entitled “A Youth-Led Citizen Science Network for Community Environmental Assessment.” ...
(Date:7/26/2019)... , ... July 25, 2019 , ... ... leaders through off-the-record collaboration and dialogue, today announces its Boston BD ... Hotel. As part of Biotech Week Boston , the event provides an ...
Breaking Biology Technology:
(Date:8/1/2019)... ... August 01, 2019 , ... USDM Life Sciences (USDM) announces that ... deliver a detailed webinar addressing challenges with the upcoming EU MDR IVDR regulations ... and has held a variety of positions over his 26 years at the FDA, ...
(Date:7/23/2019)... (PRWEB) , ... July 22, 2019 , ... Personalized Stem ... a New Drug (IND) application for use of a person’s own adipose-derived stem cells ... stem cells as a treatment of osteoarthritis in the knee. , This ...
(Date:7/17/2019)... WESTMINSTER, Colo. (PRWEB) , ... July 18, 2019 ... ... today announced the addition of Meredith James, HT, PMP, to its executive team ... in over 20 years in drug development. In her new role, Ms. James ...
Breaking Biology News(10 mins):